In prostate52 and breast cancer,50 BMP9 exerts tumour‐suppressive activity, since it inhibits migration, growth and invasion, whereas in osteosarcoma53 and ovarian cancer,54 it acts to promote proliferation. Here, GDF2 is linked to neoplasm.